PROSPECTS FOR CLINICAL USE OF EXOGENOUS INTERFERON
- 1 January 1977
- journal article
- research article
- Vol. 55 (2) , 69-73
Abstract
Sufficient quantities of human leukocyte interferon have become available for small-scale clinical studies during the past years. The present status of interferon treatment of respiratory infections, herpes keratitis, hepatitis B, osteogenic sarcoma and some other tumors is surveyed. Pharmacokinetic and toxicological data are summarized. The first clinical experiments with human fibroblast interferon have been started. Prospects for mass production of human interferons for clinical use are discussed briefly.This publication has 8 references indexed in Scilit:
- The limited in vitro lifetime of human diploid cell strainsPublished by Elsevier ,2004
- The Carrier Potential of Liposomes in Biology and MedicineNew England Journal of Medicine, 1976
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976
- ADMINISTRATION OF HUMAN FIBROBLAST INTERFERON IN CHRONIC HEPATITIS-B INFECTIONThe Lancet, 1976
- TOPICAL THERAPY OF ULCERATIVE HERPETIC KERATITIS WITH HUMAN INTERFERONThe Lancet, 1976
- Interferon Therapy in Hodgkin's DiseaseActa Medica Scandinavica, 1976
- Successful treatment of dendritic keratitis with human leukocyte interferonAlbrecht von Graefes Archiv für Ophthalmologie, 1976
- PRODUCTION OF INTERFERON BY HUMAN LEUKOCYTES IN VITRO1966